We invite you to learn more with the enclosed information or through our websites and
|
|
- Hilary McKinney
- 6 years ago
- Views:
Transcription
1 Bioventus LLC 4721 Emperor Blvd., Suite 100 Durham, NC USA P F Dear Materials Manager, Bioventus LLC, a global leader in orthobiologics, is driven to deliver clinically proven, cost-effective products that help people heal quickly and safely. The Company s innovative products include market-leading devices and therapies that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine, and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. In keeping with these commitments, we are pleased to introduce the OSTEOAMP platform of products. OSTEOAMP is a growth factor-rich bone graft substitute that is intended for homologous use for the repair, replacement, or reconstruction of musculoskeletal defects. Through proprietary methods, allograft bone and its native bone marrow are processed to preserve the naturally occurring bone morphogenetic proteins (BMP) and growth factors. The result is an osteoinductive product that fills the gap between traditional demineralized bone matrix (DBM) and recombinant human bone morphogenetic proteins (rhbmp-2). OSTEOAMP contains a wide array of naturally occurring growth factors including BMP-2, BMP-7, afgf, and TGF-β1, relative to those reported in published literature for other allografts. 1-3 We invite you to learn more with the enclosed information or through our websites and Sincerely, Bioventus Surgical Enclosures 1. Thompson N and Govil A. Osteoinductivity and Osteogenicity of Leading Allograft Bone Products. 8th Combined Meeting of Orthopaedic Research Societies. Venice, Italy. October 13-16, Chnari E, Javoroncov M, Gertzman AA, Sunwoo MH, Dunn MG. Bone Morphogenetic Protein 2 (BMP-2) Levels are Predictive of the Osteoinductive Potential of Demineralized Bone Matrix. Poster presented at: 56th Annual Meeting of the Orthopaedic Research Society; March 2010; New Orleans, LA. 3. Data on file RPT ; data from a single lot of OSTEOAMP sponge product. SMK
2
3 Bioventus LLC 4721 Emperor Blvd., Suite 100 Durham, NC USA P F Table of Certification Bioventus LLC Bioventus Exemption from FDA Tissue Establishment Licensure... 5 Distributor: Millstone Medical Outsourcing FDA Registration... 6 CA Tissue License... 7 CT Tissue License... 8 DE Tissue License... 9 FL Tissue License...10 IL Tissue License...11 LA Tissue License...12 MD Tissue License...13 NY Tissue License...14 OR Tissue License...15 Supplier: Advanced Biologics, LLC FDA Registration...18 CA Tissue License...20 FL Tissue License...21 IL Tissue License...22 MD Tissue License...23 NY Tissue License...24 OR Tissue License...25 Tissue Banks Community Tissue Services American Association of Tissue Banks...26 FDA Registration...29 CA Tissue License...30 DE Tissue License...31 FL Tissue License...32
4 IL Tissue License...33 MD Tissue License...34 NY Tissue License...35 OR Tissue License...36 DCI Donor Services, Inc. American Association of Tissue Banks...37 FDA Registration...38 CA Tissue License...39 FL Tissue License...41 MD Tissue License...42 NY Tissue License...43 OR Tissue License...45 LifeLink Tissue Bank American Association of Tissue Banks...48 FDA Registration...50 CA Tissue License...53 DE Tissue License...54 FL Tissue License...55 MD Tissue License...57 NY Tissue License...58 OR Tissue License...59 Pinnacle Transplant Technologies American Association of Tissue Banks...60 FDA Registration...62 CA Tissue License...64 DE Tissue License...65 FL Tissue License...66 MD Tissue License...67 NY Tissue License...68 OR Tissue License...70
5 All registered trademarks are owned by Bioventus LLC Bioventus LLC
6
7
8 This is your registration certificate for your records. Such registration shall be shown to any properly interested person on request. Do not attempt to make any changes or alter this certificate in any way. This registration is not transferable. We ask that you keep your information with our office current. All renewal notifications and certificates will only be ed to the last reported on record. Questions regarding this registration can be ed to the Drug Control Division at Mailing address: MILLSTONE MEDICAL OUTSOURCING LLC 8836 POLK LN STE 100 OLIVE BRANCH, MS on file to be used for receiving all notices from this office: Be it known that MILLSTONE MEDICAL OUTSOURCING LLC 8836 POLK LN STE 100 OLIVE BRANCH, MS has satisfied the qualifications required by law and is hereby issued a WHOLESALER OF DRUGS, COSMETICS & MEDICAL DEVICES Rx Legend: No DME: Cosmetics: No Non Rx Legend: Yes Medical Gas/Oxygen: Medical Devices: Yes Controlled Substances: No Registration #: CSW Effective Date: 07/01/2017 Expiration Date: 06/30/2018 verify online at
9 DELAWARE HEALTH AND SOCIAL SERVICES DIVISION OF PUBLIC HEALTH Wednesday, April 05, 2017 Patricia Pope Millstone Medical Outsourcing 8836 Polk Lane, Suite 100 Olive Branch, MS Dear Patricia Pope, This letter confirms that Millstone Medical Outsourcing is registered with the Delaware Tissue Bank until April 30, Thank you for notifying the Bureau of Communicable Diseases office in a timely manner of any changes to the information contained in the registration form. Please continue to keep contact information current to ensure timely delivery of updates and notifications. If you have any questions, please contact me at the number below, or via my . Best regards, Laureen McAleavy Delaware s Division of Public Health Bureau of Infectious Disease Prevention & Control Ph Fax Laureen.McAleavy@state.de.us
10
11 Effective Date: May 01, 2017 Expires: May 01, 2018 Patricia Pope, Tissue Bank Director 8836 Polk Lane, Suite 100 Olive Branch, MS Dear Director: Registration Number 0110 State of Illinois 2017 Sperm/Tissue Bank Registration Millstone Medical Outsourcing, LLC 8836 Polk Lane, Suite 100 Olive Branch, MS We are in receipt of your 2017 Registration with the State of Illinois. We welcome your cooperation to observe our State laws and you may use this document as proof of registration as required by Title 77 Public Health Chapter I: Department of Public Health Subchapter D: Laboratories and Blood Bank Part 470 Sperm Bank and Tissue Bank Code Section Registration Requirements. Sincerely, Juan Garcia Tissue & Sperm Bank Program Administrator Illinois Department of Public Health Health Care Facilities and Programs Laboratory Regulations Annual registration deadline is May 1, and renewal reminders are ed on February of each year.
12
13
14
15
16
17
18
19
20
21 View current license information at: Floridahealthfinder.gov View current license information at: Floridahealthfinder.gov LICENSE #: 265 CERTIFICATE #: 1177 State of Florida AGENCY FOR HEALTH CARE ADMINISTRATION DIVISION OF HEALTH QUALITY ASSURANCE Tissue Bank Licensed This is to confirm that Advanced Biologics, LLC has complied with the requirements of the State of Florida, Agency for Health Care Administration, for certification as authorized by Florida Statutes and is to operate the following: ADVANCED BIOLOGICS LLC 2800 Roosevelt St Carlsbad, CA Authorized Services: distribute tissues EFFECTIVE DATE: 04/20/2016 EPIRATION DATE: 04/19/2018 Deputy Secretary, Division of Health Quality Assurance
22
23
24 NEW YORK STATE DEPARTMENT OF HEALTH PROVISIONAL LICENSE FOR TISSUE BANK OPERATION Issued in accordance with and pursuant to section 4364 Public Health Law of New York State Tissue Bank ID No.: TS130 Director: Amit Govil President Medical Director: R. Trigg McClellan, M.D. Advanced Biologies, L.L.C. and Biologica Technologies, L.L.C Roosevelt Street Carlsbad, CA is hereby APPROVED as a Tissue Bank for the following categories of service: Tissue Storage Facility Musculoskeletal tissue Skin tissue Issued: March 4,2016 Owner: Advanced Biologies, L.L.C. and Biologica Technologies, L.L.C. Expires: April 1,2018 Property of the New York State Department of Health. Valid only at the address shown. Must be conspicuously posted. DOH-3908 (04/2001)
25
26
27
28
29 12. HCT/Ps REGULATED AS MEDICAL DEVICES 11. HCT/Ps DESCRIBED IN 21 CFR DEPARTMENT OF HEALTH AND HUMAN SERVICES 1. REGISTRATION NUMBER 2. REASON FOR SUBMISSION PUBLIC HEALTH SERVICE (FDA Establishment Identifier) a. INITIAL REGISTRATION / LISTING FOOD AND DRUG ADMINISTRATION b. ANNUAL REGISTRATION / LISTING ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES, FEI: AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps) c. CHANGE IN INFORMATION (See reverse side for instructions) d. INACTIVE PART I - ESTABLISHMENT INFORMATION PART II - PRODUCT INFORMATION 3. OTHER FDA REGISTRATIONS 10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT / Ps a. BLOOD FDA 2830 NO. FEI: Establishment Functions b. DEVICES FDA 2891 NO. Types of HCT / Ps See Instructions for OMB Statement. FORM APPROVED:OMB No Expiration Date: 3/31/2017 Recover Screen Test Package Process Store Label Distribute VALIDATION--FOR FDA USE ONLY VALIDATED BY FDA:04-FEB-2017 DISTRICT: Cincinnati PRINTED BY FDA:15-FEB HCT/Ps REGULATED AS DRUGS OR BIOLOGICAL DRUGS 14. PROPRIETARY NAME(S) 1 c. DRUG FDA 2656 NO. 4. PHYSICAL LOCATION (Include legal name, number and street, city, state, country, and post office code) Community Blood Center dba Community Tissue Services a. Bone b. Cartilage 349 S. Main Street Dayton, Ohio c. Cornea d. Dura Mater a. PHONE ET 3610 b. SATELLITE RECOVERY ESTABLISHMENT (MANUFACTURING ESTABLISHMENT FEI NO. c. TESTING FOR MICRO-ORGANISMS ONLY 5. ENTER CORRECTIONS TO ITEM 4 e. Embryo f. Fascia g. Heart Valve h. Ligament SIP Directed Anonymous 6. MAILING ADDRESS OF REPORTING OFFICIAL (Include institution name if applicable, number and street, city, state, country, and post office code) Community Blood Center dba Community Tissue Services Attn: David M. Smith, MD 349 S. Main Street Dayton, Ohio i. Oocyte j. Pericardium k. Peripheral Blood Stem SIP Directed Anonymous Autologous Family Related Allogeneic l. Sclera a. PHONE ET ENTER CORRECTIONS TO ITEM 6 b. PHONE m. Semen n. Skin SIP Directed Anonymous 8. U.S. AGENT o. Somatic Cell Therapy Products p. Tendon Autologous Family Related Allogeneic q. Umbilical Cord Blood Autologous Family Related Allogeneic a. r. Vascular Graft 9. REPORTING OFFICIAL'S SIGNATURE s. Parathyroid a. TYPED NAME David M. Smith, MD b. dsmith@cbccts.org c. TITLE CEO d. DATE 03-FEB-2017 t. u. v. Peritoneal Membrane FORM FDA (5/14)
30
31 DELAWARE HEALTH AND SOCIAL SERVICES DIVISION OF PUBLIC HEALTH Friday, April 21, 2017 Laurie Carolus Community Tissue Services--Dayton 349 S. Main St. Dayton, OH Dear Laurie Carolus, This letter confirms that Community Tissue Services Dayton is registered with the Delaware Tissue Bank until April 30, Thank you for notifying the Bureau of Communicable Diseases office in a timely manner of any changes to the information contained in the registration form. Please continue to keep contact information current to ensure timely delivery of updates and notifications. If you have any questions, please contact me at the number below, or via my . Best regards, Laureen McAleavy Delaware s Division of Public Health Bureau of Infectious Disease Prevention & Control Ph Fax Laureen.McAleavy@state.de.us
32 View current license information at: Floridahealthfinder.gov View current license information at: Floridahealthfinder.gov LICENSE #: 41 CERTIFICATE #: 1232 State of Florida AGENCY FOR HEALTH CARE ADMINISTRATION DIVISION OF HEALTH QUALITY ASSURANCE Tissue Bank Licensed This is to confirm that Community Blood Center has complied with the requirements of the State of Florida, Agency for Health Care Administration, for certification as authorized by Florida Statutes and is to operate the following: COMMUNITY TISSUE SERVICES 2900 College Dr Kettering, OH Authorized Services: distribute tissues EFFECTIVE DATE: 11/03/2016 EPIRATION DATE: 11/02/2018 Deputy Secretary, Division of Health Quality Assurance
33 Effective Date: May 01, 2017 Expires: May 01, 2018 Diane Wilson, Tissue Bank Director 2900 College Drive Kettering, OH Dear Director: Registration Number 0911 State of Illinois 2017 Sperm/Tissue Bank Registration Community Blood Center D/B/A Community Tissue Services 2900 College Drive Kettering, OH We are in receipt of your 2017 Registration with the State of Illinois. We welcome your cooperation to observe our State laws and you may use this document as proof of registration as required by Title 77 Public Health Chapter I: Department of Public Health Subchapter D: Laboratories and Blood Bank Part 470 Sperm Bank and Tissue Bank Code Section Registration Requirements. Sincerely, Juan Garcia Tissue & Sperm Bank Program Administrator Illinois Department of Public Health Health Care Facilities and Programs Laboratory Regulations Annual registration deadline is May 1, and renewal reminders are ed on February of each year.
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50 12. HCT/Ps REGULATED AS MEDICAL DEVICES 11. HCT/Ps DESCRIBED IN 21 CFR DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps) (See reverse side for instructions) PART I - ESTABLISHMENT INFORMATION 3. OTHER FDA REGISTRATIONS a. BLOOD FDA 2830 b. DEVICES FDA 2891 NO. NO. FEI: d. INACTIVE PART II - PRODUCT INFORMATION 10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT / Ps Establishment Functions Types of HCT / Ps See Instructions for OMB Statement. FORM APPROVED:OMB No Expiration Date: 3/31/ REGISTRATION NUMBER 2. REASON FOR SUBMISSION (FDA Establishment Identifier) a. INITIAL REGISTRATION / LISTING b. ANNUAL REGISTRATION / LISTING c. CHANGE IN INFORMATION Recover Screen Test Package Process Store Label Distribute VALIDATION--FOR FDA USE ONLY VALIDATED BY FDA:16-NOV-2016 DISTRICT: Atlanta PRINTED BY FDA:16-DEC HCT/Ps REGULATED AS DRUGS OR BIOLOGICAL DRUGS 14. PROPRIETARY NAME(S) 1 c. DRUG FDA 2656 NO. 4. PHYSICAL LOCATION (Include legal name, number and street, city, state, country, and post office code) Lifelink of Georgia (Atlanta Office) a. Bone b. Cartilage 2875 Northwoods Pkwy Norcross, Georgia c. Cornea d. Dura Mater a. PHONE ET b. SATELLITE RECOVERY ESTABLISHMENT (MANUFACTURING ESTABLISHMENT FEI NO. c. TESTING FOR MICRO-ORGANISMS ONLY 5. ENTER CORRECTIONS TO ITEM 4 e. Embryo f. Fascia g. Heart Valve h. Ligament SIP Directed Anonymous 6. MAILING ADDRESS OF REPORTING OFFICIAL (Include institution name if applicable, number and street, city, state, country, and post office code) Kathy Lilly Attn: Kathy Lilly 2875 Northwoods Pkwy Norcross, Georgia i. Oocyte j. Pericardium k. Peripheral Blood Stem SIP Directed Anonymous Autologous Family Related Allogeneic l. Sclera a. PHONE ET 7. ENTER CORRECTIONS TO ITEM 6 b. PHONE m. Semen n. Skin SIP Directed Anonymous o. Somatic Cell Therapy Products Autologous Family Related Allogeneic 8. U.S. AGENT p. Tendon q. Umbilical Cord Blood Autologous Family Related Allogeneic a. r. Vascular Graft 9. REPORTING OFFICIAL'S SIGNATURE s. a. TYPED NAME Kathy Lilly b. kathleen.lilly@lifelinkfound.org c. TITLE V.P./ Exec. Director FORM FDA (5/14) d. DATE 15-NOV-2016 t. u. v.
51 12. HCT/Ps REGULATED AS MEDICAL DEVICES 11. HCT/Ps DESCRIBED IN 21 CFR DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps) (See reverse side for instructions) PART I - ESTABLISHMENT INFORMATION 3. OTHER FDA REGISTRATIONS a. BLOOD FDA 2830 b. DEVICES FDA 2891 NO. NO. d. INACTIVE PART II - PRODUCT INFORMATION 10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT / Ps Establishment Functions Types of HCT / Ps See Instructions for OMB Statement. FORM APPROVED:OMB No Expiration Date: 3/31/ REGISTRATION NUMBER 2. REASON FOR SUBMISSION (FDA Establishment Identifier) a. INITIAL REGISTRATION / LISTING FEI: b. ANNUAL REGISTRATION / LISTING c. CHANGE IN INFORMATION Recover Screen Test Package Process Store Label Distribute VALIDATION--FOR FDA USE ONLY VALIDATED BY FDA:19-NOV-2016 DISTRICT: Florida PRINTED BY FDA:15-DEC HCT/Ps REGULATED AS DRUGS OR BIOLOGICAL DRUGS 14. PROPRIETARY NAME(S) 1 c. DRUG FDA 2656 NO. 4. PHYSICAL LOCATION (Include legal name, number and street, city, state, country, and post office code) LifeLink Tissue Bank - Orlando a. Bone b. Cartilage LifeGraft, TruArc, LifeFlex 1739 South Orange Ave. Orlando, Florida c. Cornea d. Dura Mater a. PHONE ET b. SATELLITE RECOVERY ESTABLISHMENT (MANUFACTURING ESTABLISHMENT FEI NO. c. TESTING FOR MICRO-ORGANISMS ONLY 5. ENTER CORRECTIONS TO ITEM 4 e. Embryo f. Fascia g. Heart Valve h. Ligament SIP Directed Anonymous 6. MAILING ADDRESS OF REPORTING OFFICIAL (Include institution name if applicable, number and street, city, state, country, and post office code) LifeLink Tissue Bank Attn: Elizabeth S. Horn-Brinson, BS 9661 Delaney Creek Boulevard Tampa, Florida i. Oocyte j. Pericardium k. Peripheral Blood Stem SIP Directed Anonymous Autologous Family Related Allogeneic l. Sclera a. PHONE ET ENTER CORRECTIONS TO ITEM 6 b. PHONE m. Semen n. Skin SIP Directed Anonymous o. Somatic Cell Therapy Products Autologous Family Related Allogeneic 8. U.S. AGENT p. Tendon q. Umbilical Cord Blood Autologous Family Related Allogeneic a. r. Vascular Graft 9. REPORTING OFFICIAL'S SIGNATURE s. a. TYPED NAME Elizabeth S. Horn-Brinson, BS b. liz.brinson@lifelinkfound.org c. TITLE VP, QA FORM FDA (5/14) d. DATE 18-NOV-2016 t. u. v.
52 12. HCT/Ps REGULATED AS MEDICAL DEVICES 11. HCT/Ps DESCRIBED IN 21 CFR DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps) (See reverse side for instructions) PART I - ESTABLISHMENT INFORMATION 3. OTHER FDA REGISTRATIONS a. BLOOD FDA 2830 b. DEVICES FDA 2891 NO. NO. FEI: d. INACTIVE PART II - PRODUCT INFORMATION 10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT / Ps Establishment Functions Types of HCT / Ps See Instructions for OMB Statement. FORM APPROVED:OMB No Expiration Date: 3/31/ REGISTRATION NUMBER 2. REASON FOR SUBMISSION (FDA Establishment Identifier) a. INITIAL REGISTRATION / LISTING b. ANNUAL REGISTRATION / LISTING c. CHANGE IN INFORMATION Recover Screen Test Package Process Store Label Distribute VALIDATION--FOR FDA USE ONLY VALIDATED BY FDA:19-NOV-2016 DISTRICT: San Juan PRINTED BY FDA:15-DEC HCT/Ps REGULATED AS DRUGS OR BIOLOGICAL DRUGS 14. PROPRIETARY NAME(S) 1 c. DRUG FDA 2656 NO. 4. PHYSICAL LOCATION (Include legal name, number and street, city, state, country, and post office code) Lifelink of Puerto Rico a. Bone b. Cartilage Daimler-Chrysler Bldg./Metro Office Park Street 1 # 1, Suite 100 Guaynabo, Puerto Rico c. Cornea d. Dura Mater a. PHONE ET b. SATELLITE RECOVERY ESTABLISHMENT (MANUFACTURING ESTABLISHMENT FEI NO. c. TESTING FOR MICRO-ORGANISMS ONLY 5. ENTER CORRECTIONS TO ITEM 4 e. Embryo f. Fascia g. Heart Valve h. Ligament SIP Directed Anonymous 6. MAILING ADDRESS OF REPORTING OFFICIAL (Include institution name if applicable, number and street, city, state, country, and post office code) LifeLink Tissue Bank Attn: Elizabeth S. Horn-Brinson 9661 Delaney Creek Boulevard Tampa, Florida i. Oocyte j. Pericardium k. Peripheral Blood Stem SIP Directed Anonymous Autologous Family Related Allogeneic l. Sclera a. PHONE ET ENTER CORRECTIONS TO ITEM 6 b. PHONE m. Semen n. Skin SIP Directed Anonymous o. Somatic Cell Therapy Products Autologous Family Related Allogeneic 8. U.S. AGENT p. Tendon q. Umbilical Cord Blood Autologous Family Related Allogeneic a. r. Vascular Graft 9. REPORTING OFFICIAL'S SIGNATURE s. a. TYPED NAME Elizabeth S. Horn-Brinson b. liz.brinson@lifelinkfound.org c. TITLE VP, QA FORM FDA (5/14) d. DATE 18-NOV-2016 t. u. v.
53
54 DELAWARE HEALTH AND SOCIAL SERVICES DIVISION OF PUBLIC HEALTH Thursday, April 06, 2017 Elizabeth Horn-Brinson LifeLink Tissue Bank Tampa, FL Dear Elizabeth Horn-Brinson, This letter confirms that LifeLink Tissue Bank is registered with the Delaware Tissue Bank until April 30, Thank you for notifying the Bureau of Communicable Diseases office in a timely manner of any changes to the information contained in the registration form. Please continue to keep contact information current to ensure timely delivery of updates and notifications. If you have any questions, please contact me at the number below or via my . Best regards, Laureen McAleavy Delaware s Division of Public Health Bureau of Infectious Disease Prevention & Control Ph Fax Laureen.McAleavy@state.de.us
55 View current license information at: Floridahealthfinder.gov View current license information at: Floridahealthfinder.gov LICENSE #: 163 CERTIFICATE #: 1203 State of Florida AGENCY FOR HEALTH CARE ADMINISTRATION DIVISION OF HEALTH QUALITY ASSURANCE Tissue Bank Licensed This is to confirm that Lifelink Foundation Inc has complied with the requirements of the State of Florida, Agency for Health Care Administration, for certification as authorized by Florida Statutes and is to operate the following: LIFELINK TISSUE BANK 9661 Delaney Creek Blvd Tampa, FL Authorized Services: recover, process, distribute and storage tissues EFFECTIVE DATE: 08/17/2016 EPIRATION DATE: 08/16/2018 Deputy Secretary, Division of Health Quality Assurance
56 View current license information at: Floridahealthfinder.gov View current license information at: Floridahealthfinder.gov LICENSE #: 155 CERTIFICATE #: 1142 State of Florida AGENCY FOR HEALTH CARE ADMINISTRATION DIVISION OF HEALTH QUALITY ASSURANCE Tissue Bank Licensed This is to confirm that Lifelink Foundation Inc has complied with the requirements of the State of Florida, Agency for Health Care Administration, for certification as authorized by Florida Statutes and is to operate the following: LIFELINK TISSUE BANK - ORLANDO 1739 S Orange Ave Orlando, FL Authorized Services: distribute and storage tissues EFFECTIVE DATE: 03/09/2016 EPIRATION DATE: 03/08/2018 Deputy Secretary, Division of Health Quality Assurance
57
58
59
60
61
62
63
64
65
66 View current license information at: Floridahealthfinder.gov View current license information at: Floridahealthfinder.gov LICENSE #: 184 CERTIFICATE #: 1163 State of Florida AGENCY FOR HEALTH CARE ADMINISTRATION DIVISION OF HEALTH QUALITY ASSURANCE Tissue Bank Licensed This is to confirm that Pinnacle Transplant Technologies LLC has complied with the requirements of the State of Florida, Agency for Health Care Administration, for certification as authorized by Florida Statutes and is to operate the following: PINNACLE TRANSPLANT TECHNOLOGIES LLC 1125 W Pinnacle Peak Rd Bldg 2 Phoenix, AZ Authorized Services: distribute tissues EFFECTIVE DATE: 01/24/2016 EPIRATION DATE: 01/23/2018 Deputy Secretary, Division of Health Quality Assurance
67
68
69
70
71
72
We invite you to learn more with the enclosed information or through our websites and
Bioventus LLC 4721 Emperor Blvd., Suite 100 Durham, NC 27703 USA P 800.637.4391 F 888.279.0152 www.bioventussurgical.com Dear Materials Manager, Bioventus LLC, a global leader in orthobiologics, is driven
More informationHANS BIOMED USA, Inc. 140 sylvan Ave Suite #4 Englewood Cliffs, NJ TEL FAX:
HANS BIOMED USA, Inc. 140 sylvan Ave Suite #4 Englewood Cliffs, NJ 07632 TEL 201 2242333 FA: 201 221 2330 Aug 2, 2016 To Whom it May Concern, Hans Biomed manufactures ExponentT M DBM and PureBone Demineralized
More informationFDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps
FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps September 27, 2018 Presentation by: Elaine H. Tseng Partner FDA and Life Sciences Group King & Spalding Discussion with: Thomas Poché Vice
More informationSafa Karandish Office of Tissues and Advanced Therapies Division of Human Tissues. Pharma Conference February
Safa Karandish Office of Tissues and Advanced Therapies Division of Human Tissues Pharma Conference February 2017 1 Background HCT/P regulatory framework Definitions & exceptions Establishment registration-
More informationHCT/P Regulation vs 361 Products
HCT/P Regulation - 351 vs 361 Products Presented by: Paul Gadiock February 15, 2017 Arent Fox LLP Washington, DC New York, NY Los Angeles, CA San Francisco, CA 1 Presentation Overview Introduction Public
More informationCertifications: Table of Contents. Document # Title Page(s)
Certifications: Table of Contents Document # Title Page(s) 1 ISO 17025: Certificate of Accreditation 2 2 ISO 17025: Scope of Accreditation 3-7 3 FDA: Medical Device Establishment 8 Registration 4 FDA:
More informationCertifications: Table of Contents. Document # Title Page(s)
Certifications: Table of Contents Document # Title Page(s) 1 ISO 17025: Certificate of Accreditation 2 2 ISO 17025: Scope of Accreditation 3-6 3 FDA: Medical Device Establishment 7 Registration 4 FDA:
More information2015-Tissue Storage. Welcome to the 2015 Tissue Storage survey. Please refer to the following instructions as you complete this section of the survey.
2015-Tissue Storage Form Approved OMB No. 0990-0457 Exp. Date 06/30/2020 Welcome to the 2015 Tissue Storage survey. Please refer to the following instructions as you complete this section of the survey.
More informationHuman Tissue Intended for Transplantation Skin, corneas, sclera, bone, heart valves, blood vessels, pericardium, tendons, cartilage, fascia
TITLE / DESCRIPTION: DEPARTMENT: Human Tissue Intended for Transplantation Skin, corneas, sclera, bone, heart valves, blood vessels, pericardium, tendons, cartilage, fascia Surgical Services PERSONNEL:
More information2012-Tissue Distribution
2012-Tissue Distribution Form Approved OMB. 0990-0457 Exp. Date 06/30/2020 Welcome to the 2012 Tissue Distribution survey. Please refer to the following instructions as you complete this section of the
More informationFDA s Same Surgical Procedure Draft Guidance Could Stifle Use of Autologous Stem Cell Therapies
FDA s Same Surgical Procedure Draft Guidance Could Stifle Use of Autologous Stem Cell Therapies Executive Summary, June 2015 Life Sciences Practice Group AUTHOR Areta L. Kupchyk Nixon Peabody LLP Washington,
More informationFDA Approach to the Regulation of Hematopoietic Stem/Progenitor Cells (HPC)
FDA Approach to the Regulation of Hematopoietic Stem/Progenitor Cells (HPC) Ellen Lazarus, M.D. Medical Officer Division of Human Tissues Office of Cellular, Tissue, and Gene Therapies FDA proposed approach
More informationUDI Guidance Document for Medical Devices Containing HCT/P
LEARNING UDI COMMUNITY UDI Guidance Document for Medical Devices Containing HCT/P WWW.AHRMM.ORG / LUC INTRODUCTION: Human cells, tissues, or cellular or tissue-based products (HCT/Ps) are a precious resource
More information2015-Tissue Bank Processing
2015-Tissue Bank Processing Form Approved OMB No. 0990-0457 Exp. Date 06/30/2020 Welcome to the 2015 Tissue Processing survey. Please refer to the following instructions as you complete this section of
More informationImporting/Exporting Conventional HCT/Ps
Importing/Exporting Conventional HCT/Ps ISCT/FDA Liaison Meeting January 4, 2007 Scott A. Brubaker, CTBS American Association of Tissue Banks Conventional Tissue Banks! FDA term from the preamble to the
More information3/20/2017. R 3 Repair Paradigm REGENERATIVE MEDICINE GLOSSARY OF STEM CELL PLATFORMS. Limitations of Embryonic Stem Cells
R 3 Repair Paradigm CENTER FOR REGENERATIVE MEDICINE Regenerative Medicine Regulatory And Practice Management Focus Replacement ACL/UCL Reconstruction Regeneration Next generation therapy Repair Rejuvenation
More informationRegulatory Issues in Human Subjects Research
Regulatory Issues in Human Subjects Research Ian McNiece, PhD University of Miami Human Subjects Research Require IRB approval Studies of new drugs or applications of drugs require an FDA approved IND
More informationSharon Tindle, MS, CQA (ASQ) QA Manager, BMT Tissue Services Mount Sinai Hospital, New York, NY. June 7, 2016
Sharon Tindle, MS, CQA (ASQ) QA Manager, BMT Tissue Services Mount Sinai Hospital, New York, NY June 7, 2016 1 Brief description of the Mount Sinai Cellular Therapy Laboratory Overview of BM transplant
More informationMartha A Wells, MPH Division of Human Tissues OCTGT, CBER, FDA. Pharma Conference HCT/P Meeting January 24, 2007 San Antonio, TX
Guidance for Industry: Certain Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Recovered From Donors Who Were Tested For Communicable Diseases Using Pooled Specimens or Diagnostic
More informationRegulatory Considerations for Human Cell, Tissues, and Cellular and Tissue- Based Products: Minimal Manipulation and Homologous Use
Regulatory Considerations for Human Cell, Tissues, and Cellular and Tissue- Based Products: Minimal Manipulation and Homologous Use Guidance for Industry and Food and Drug Administration Staff For questions
More informationSubj: ESTABLISHMENT OF A HUMAN CELL, TISSUE, AND CELLULAR AND TISSUE-BASED PRODUCTS MANAGEMENT PROGRAM
DEPARTMENT OF THE NAVY BUREAU OF MEDICINE AND SURGERY 7700 ARLINGTON BOULEVARD FALLS CHURCH, VA 22042 IN REPLY REFER TO ` BUMEDINST 6300.21 BUMED-M3 BUMED INSTRUCTION 6300.21 From: Chief, Bureau of Medicine
More informationJune 10, In Re: Draft Request for Proposal for Biological Implants, Solicitation Number: VA11916R0139
June 10, 2016 Henry T. Wells U.S. Department of Veterans Affairs Strategic Acquisition Center 10300 Spotsylvania Ave. Fredericksburg VA 22408 In Re: Draft Request for Proposal for Biological Implants,
More informationCBER Regulation of Devices for Cell Therapy
CBER Regulation of Devices for Cell Therapy Richard D. McFarland, Ph.D., M.D. Associate Director for Policy Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and Research Food
More informationFAQ ABOUT. 21CFR Part 1271 FDA REGULATION OF REPRODUCTIVE TISSUE LABS
FAQ ABOUT 21CFR Part 1271 FDA REGULATION OF REPRODUCTIVE TISSUE LABS XYTEX INTERNATIONAL, LTD. AUGUSTA, GEORGIA NOVEMBER 2005 Xytex International, 2005 Xytex is a registered trademark of Xytex International,
More informationInspection of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
COMPLIANCE PROGRAM GUIDANCE MANUAL Inspection of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) 7341.002 Implementation Date: Completion Date: when posted on-going Program/Assignment
More informationDevelopment of Regenerative Medicine Products: FDA Perspectives
資料 3-3 Development of Regenerative Medicine Products: FDA Perspectives Steven R. Bauer, Ph.D. Chief, Cellular and Tissue Therapies Branch Office of Cellular, Tissue and Gene Therapies Center for Biologics
More informationSpecial Report. medicine? Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D.
The new england journal of medicine Special Report Balancing Safety and Innovation for Cell-Based Regenerative Medicine Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D. Regenerative medicine is a field
More informationReporting Deviations of Biological Products and HCT/Ps. Ellen Areman Senior Consultant Biologics Consulting Group, Inc.
Reporting Deviations of Biological Products and HCT/Ps Ellen Areman Senior Consultant Biologics Consulting Group, Inc. Relevant Legislation Public Health Service (PHS) Act Regulates biological products
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Thomas E. Young,
More informationOsteobiologic B O N E G R A F T I N G S O L U T I O N S
Osteobiologic BONE GRAFTING SOLUTIONS The AlloSource Advantage Delivering Quality and Safety * Allografts labeled Sterile R are aseptically processed and packaged and then subjected to gamma irradiation.
More informationChallenges In Cell Product Labeling, Tracking And Traceability
Challenges In Cell Product Labeling, Tracking And Traceability April 4-5, 2008 Columbus, Ohio Dave Krugh, MT(ASCP)SBB, CLS,CLCP(NCA) Clinical Program Manager, BMT Program Clinical Instructor, Department
More informationTissue Engineered Medical Products
WORKSHOP 8 Tissue Organizer: Jeremy J. Rawlinson PhD Speakers: Jack E. Lemons, PhD Lawrence J. Bonassar, PhD Mauro R. Alini, PhD Michael J. Yaszemski, MD, PhD Standards for Tissue J. Lemons, University
More informationQuality Program: Supplies and Reagents
Quality Program: Supplies and Reagents J. Wade Atkins, MS, MT(ASCP) SBB, CQA (ASQ) Supervisor, Quality Assurance and Regulatory Affairs Department of Transfusion Medicine, Clinical Center, NIH Disclosures:
More informationEmbryonic Stem Cell Research Oversight Committee (ESCRO) Application Form
Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form A. Demographic Information Date of Submission: Reason for Submission: New Project Response to Comments Reconsideration Disapproval
More informationBUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.
BUILT TO CONCENTRATE Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care. DELIVER PERSONALIZED MEDICINE Every patient has a unique biology
More informationTissue cleaning and sterilization provide an additional level of safety
Managing biologics Understanding tissue processing Third in a series on managing bone allografts. In the October issue, articles included were Allografts: Overview of the process; and Donor screening:
More informationGuidance for Industry
Guidance for Industry Cooperative Manufacturing Arrangements for Licensed Biologics Additional copies of this guidance are available from the Office of Communication, Training and Manufacturers Assistance
More informationStem Cell Therapy for Wound Healing in Diabetic Limb
Stem Cell Therapy for Wound Healing in Diabetic Limb Tanom Bunaprasert M.D. EC-ATMPs ( EC- Advanced Therapy Medicinal Products) Chulalongkorn Hospital Authority of Laws Public Health Safety act (
More informationRegulation of Biologics in The United States: From a Rich Tradition To A Challenging Future
Regulation of Biologics in The United States: From a Rich Tradition To A Challenging Future Chris Joneckis,, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Food and Drug
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for Product Registration OTC Drugs (Main & Identical) Form.: DBPR-DDC-231 APPLICATION
More informationROLL CALL PURCHASE RECOMMENDATIONS
28 Board Meeting July 13, 2017 ROLL CALL PURCHASE RECOMMENDATIONS The "Purchase Recommendations" are presented by campus and a Summary from "Appropriated Funds" (i.e., from State appropriations to the
More informationSouth Carolina Donor Registry Q & A
South Carolina Donor Registry Q & A How do I become a registered organ and tissue donor? There are several ways to register your legal consent to be a donor: 1.) At any SCDMV office or on the SCDMV web
More informationQuality Manual. Quality Manual. Vera Bioscience / Anu Life Sciences. April 2018
Quality Manual Vera Bioscience / Anu Life Sciences April 2018 Page 1 of 15 TABLE OF CONTENTS Quality Manual Page 1. Company Overview 3 2. References 3 3. Exemptions, Alternatives and Variances 3 4. General
More informationHCT/P Deviations & Reporting. 13 th ANNUAL FDA & The Changing Paradigm for HCT/P Regulation February 13-15, 2017
HCT/P Deviations & Reporting CASE STUDIES FROM TISSUE AND EYE BANKS AND CELLULAR THERAPY. 13 th ANNUAL FDA & The Changing Paradigm for HCT/P Regulation February 13-15, 2017 Tissue Bank Perspective Ashley
More informationMeeting with the U.S. FDA Center for Biologics Evaluation and Research Thursday, March 8, 2018, Silver Spring, MD, U.S.A.
Ref. Ares(2018)4414549-28/08/2018 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Directorate B - Health systems, medical products and innovation B4 Medical products: quality, safety
More informationFDA Regulation of Stem Cell Therapies. Regulation of adipose derived stromal preps
2018 FDA Regulation of Stem Cell Therapies Regulation of adipose derived stromal preps EMERGING NEW FIELD BUT STILL A TODDLER Regenerative medicine technologies for orthopedic medicine application has
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 19.6.2002 COM(2002) 319 final 2002/0128(COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on setting standards of quality and
More informationFOR IMMEDIATE RELEASE
FOR IMMEDIATE RELEASE Media Contact: Melanie Battista, Public Relations (TSX-V: LBL) (OTCBB: BLVKF) 16701 N 90th Street, Suite#101 Scottsdale, AZ 85260 480-563-0800 Office News@LatticeBiologics.com www.latticebiologics.com
More informationEMA s role & responsibility for the development of modern/advanced therapies
EMA s role & responsibility for the development of modern/advanced therapies Agenda Current regulatory picture Overall Regulatory framework New Committee at EMA Current Activities & Challenges Egbert Flory
More informationIS HE SPEAKING ENGLISH? cgmp: : Current Good Manufacturing Practice PHS Act: : Public Health Service Act CFR: : Code of Federal Regulations CP: : Comp
PREPARING FOR AN FDA INSPECTION August 11, 2011 Kip J. Hanks, Investigator Biologics National Expert FDA Division of Domestic Field Investigations 1 IS HE SPEAKING ENGLISH? cgmp: : Current Good Manufacturing
More information*NOTIFY THE DEPARTMENT IN WRITING OF ANY UPDATES
APPLICATION FOR A PERMIT UNDER CHAPTER 499, FLORIDA STATUTES Florida Department of Business and Professional Regulation Drugs, Devices, and Cosmetics Program 1940 North Monroe Street, Tallahassee FL 323990783
More informationCurrent Challenges of Regulation in Japan - Amendment of Pharmaceutical Affairs Act
Current Challenges of Regulation in Japan - Amendment of Pharmaceutical Affairs Act Hiroshi Yamamoto, MS Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan 26th Annual EuroMeeting
More informationPRIME-XV Hematopoietic Cell Basal XSFM
PRIME-XV Hematopoietic Cell Basal XSFM Xeno-free, serum-free basal medium for human hematopoietic progenitor cell culture Optimized to support vigorous expansion of hematopoietic progenitor cells while
More informationFDA Inspections: FDA Inspections: An Overview Overview
FDA Inspections: An Overview Robert Lindblad, MD The EMMES Corporation August 11, 2011 researchcartoons.com Why Inspections? Why Inspections? To evaluate compliance with regulations To establish that an
More informationThe transition to OptumRx is designed to help us better serve your employees and help improve their overall experience:
September 27, 2013 RE: Pharmacy Benefit Transition Plan for Oxford Clients Dear Valued Oxford Client, We are pleased to confirm that, effective Oct. 1, 2013, your pharmacy benefit services are being administered
More informationThe FDA/CDRH Perspective in the Regulation of Surgical Mesh
The FDA/CDRH Perspective in the Regulation of Surgical Mesh David Krause, Ph.D., Branch Chief Plastic & Reconstructive Surgery Branch Division of Surgical, Orthopedic & Restorative Devices Office of Device
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Celltex Therapeutics Corporation
More informationStem Cells, Regenerative Medicine and cgmp (GTP)
Stem Cells, Regenerative Medicine and cgmp (GTP) Encompass Stem cell based therapies activities Collection source Purification Isolation from other cell types if needed Manipulation Minimal vs Moderate
More informationAPR Dear Ms. Adair:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 2 7 2004 Ms. Kaoru L. Adair Vice President Regulatory Affairs and
More informationRegulatory frameworks of regenerative medicines and products review in Japan
Regulatory frameworks of regenerative medicines and products review in Japan August 27th, 2018 Kenji KUROIWA Deputy Director, Medical Devices Evaluation Division Ministry of Health, Labour and Welfare,
More informationUniversity of Rochester
University of Rochester Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form A. General Information Reason for Submission to ESCRO: New Project Response to Comments Reconsideration
More informationFor personal use only
Quarterly Cash Flow Report June 2016 Perth, Australia; 29 April 2016: Orthocell Limited s Quarterly Cash Flow Report for the quarter ended 30 June 2016 is attached. Orthocell is a commercial-stage, regenerative
More informationANDREW BALO SENIOR VICE PRESIDENT, REGULATORY, BIOMETRICS, & CLINICAL AFFAIRS DEXCOM, INC 6340 SEQUENCE DRIVE SAN DIEGO, CA 92121
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 23, 2015 ANDREW
More informationNOTICE OF INITIATION OF DISQUALIFICATION PROCEEDING AND OPPORTUNITY TO EXPLAIN
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Center for Biologics Evaluation and Research 1401 Rockville Pike Rockville, MD 20852-1448 By Facsimile Transmission and Overnight Delivery
More informationClear Creek Fire Authority Firefighter Application
Clear Creek Fire Authority Firefighter Application Your completed application should be returned by mail, email or fax to: Clear Creek Fire Authority Attention: Recruiting PO Box 507 681 County Road 308
More informationPresentation of Capabilities Reverse Logistics
Presentation of Capabilities Reverse Logistics Woodfield Distribution, LLC v081617 Reverse Logistics About Us Description of Services Reverse Distribution Channels DSCSA/Sustainability About Us WDSrx Woodfield
More informationPoint-of-Care Cell Processing Devices A Manufacturer s Perspective Clinical trials, regulatory compliance, and commercialization.
Philadelphia, 2013 Point-of-Care Cell Processing Devices A Manufacturer s Perspective Clinical trials, regulatory compliance, and commercialization. Brian Barnes, Ph.D. VP, Clinical and Regulatory Affairs
More informationAgenzia Italiana del Farmaco
Agenzia Italiana del Farmaco European Regulation on Advanced Therapies Cristina Pintus Head of European Relations Unit and Coordinator of the Advanced Therapy Project Italian Medicines Agency Proposal
More informationProcessed from Donated Human Tissue by LifeCell Corporation for KCI USA, Inc.
for wounds instructions for use Processed from Donated Human Tissue by LifeCell Corporation for KCI USA, Inc. marketed by KCI USA, Inc. San Antonio, TX 78219 USA 800.275.4524 www.kci1.com www.graftjacketbykci.com
More informationCopyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.
Statutory Framework for Biologics Drugs Investigational Use Application IND Pre-Market Approval Applications 505(b)(1) NDA 505(b)(2) NDA 505(j) ANDA Over-the-Counter (OTC) Non- Rx Drugs Monograph Biologics
More informationThis guidance is for immediate implementation.
Requirements for Transactions with First Responders under Section 582 of the Federal Food, Drug, and Cosmetic Act Compliance Policy Guidance for Industry This guidance is for immediate implementation.
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Inspections, Compliance, Enforcement, Criminal Investigations Crothall Healthcare, Inc. Department of Health Human Services Public Health Service Food Drug Administration New Orleans District 404 BNA Drive
More informationFDA: The New Animal Drug Approval Process and Cell Based Products
FDA: The New Animal Drug Approval Process and Cell Based Products Lynne Boxer, DVM March 29, 2017 Division of Therapeutic Drugs for Non Food Animals Office of New Animal Drug Evaluation Center for Veterinary
More information3/17/2017. Scope. Guidance 218: Cell Based Products for Animal Use. FDA: The New Animal Drug Approval Process and Cell Based Products
FDA: The New Animal Drug Approval Process and Cell Based Products Lynne Boxer, DVM March 29, 2017 Division of Therapeutic Drugs for Non Food Animals Office of New Animal Drug Evaluation Center for Veterinary
More informationFebruary 17, DSM Biomedical Ms. Brianna Jordan Regulatory Specialist 735 Pennsylvania Drive Exton, Pennsylvania 19341
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 February 17, 2015 DSM
More informationGuidance for Industry
Guidance for Industry Cooperative Manufacturing Arrangements for Licensed Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationQuality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits
Quality Assurance QA 601.01 STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick
More informationTitle II Licensure of Wholesale Distributors and 3PL s:
Title II Licensure of Wholesale Distributors and 3PL s: Where does FDA stand, where do states stand, what about VAWD, and what can you do about it? Elizabeth A. Gallenagh, Senior Vice President, Government
More informationTITLE: Implantable Tissue: Receipt, Storage, Use and Documentation
PAGE 1 of 5 TITLE: Implantable Tissue: Receipt, Storage, Use and Documentation IDENTIFIER: S-FW-TS-0002 APPROVED: Executive Cabinet 2/20/18 ORIGINAL: 09/14 REVISED: 2/18 REVIEWED: EFFECTIVE DATE: 3/6/18
More informationThe Ultimate Guide To STEM CELL THERAPY. for Joint Disorders
The Ultimate Guide To STEM CELL THERAPY for Joint Disorders Who Are We? The Regenerative Orthopedic Clinic is a state-of-the-art medical facility that offers a number of services for non-surgical joint
More information07/30/2013. Record of Revisions IRB Page 1 of 17
Current Protocol Version 7.1 (Continuing Review) Approved July 30, 2013 Version 7.1 (Amendment) September 6, 2012 Version 7.0 (Continuing Review) July 30, 2012 Version 6.0 (Continuing Review) July 30,
More information_ll:c 11Ob CONSUMER ENERGY SOLUTIONS. INC Cleveland Street, Clearwater, Florida, December 14, 2016
IM C- _ll:c 11Ob CONSUMER ENERGY SOLUTIONS. INC. 1255 Cleveland Street, Clearwater, Florida, 33755 December 14, 2016 New Hampshire Public Utilities Commission Debra Howland, Executive Director 21 South
More informationANAT 2341 Embryology Lecture 18 Stem Cells
ANAT 2341 Embryology Lecture 18 Stem Cells 29 September 2010 Dr Antonio Lee Neuromuscular & Regenera
More informationJose Giron 5/19/16. Protecting and Promoting Your Health. Public Health Service Food and Drug Administration Silver Spring, MD WARNING LETTER
U.S. Food and Drug Administration Protecting and Promoting Your Health Jose Giron 5/19/16 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993
More informationStandards and Regulatory Considerations for Orthopaedic Implants
Standards and Regulatory Considerations for Orthopaedic Implants Constituencies Patients Payers (Insurance) Physicians Manufacturers Research Community Government Legal Community Professional Organizations
More informationApril 22, Trilliant Surgical, Limited Mr. J.D. Webb President The Orthomedix Group, Incorporated 1001 Oakwood Boulevard Round Rock, Texas 78681
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Trilliant Surgical,
More informationDiscover TruPRP. PRP the way you want it.
Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet
More informationDEC DEPARTMENT OF HEALTH & HUMAN SERVICES
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -W066-G609 Silver Spring, MD 20993-0002 Ms. Victoria Rendon Senior
More informationMedical Devices; Neurological Devices; Classification of the Evoked Photon Image Capture
This document is scheduled to be published in the Federal Register on 09/30/2016 and available online at https://federalregister.gov/d/2016-23633, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationEMPLOYMENT APPLICATION
UNION COUNTY BOARD OF DEVELOPMENTAL DISABILITIES 1280 Charles Lane Marysville, Ohio 43040 (937) 645-6733 EMPLOYMENT APPLICATION Name Last First Middle Date TO ALL APPLICANTS (please read carefully) Thank
More informationFAIRCHILD APPLICATION FOR EMPLOYMENT
APPLICATION FOR EMPLOYMENT Driver Requirements A driver must meet the following requirements: Be in good health and physically able to perform all duties of a driver. Be at least 21 years of age. Speak
More informationRegulatory Perspectives of Japan
International Alliance for Biological Standardization (IABS) Challenge Toward Sound Scientific Regulation of Cell Therapy Products at Kyoto International Conference Center, Kyoto, Japan Regulatory Perspectives
More informationAdvanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4. Relevant Financial Relationships - None
EAHP March 2016 Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4 Dr. Lenka Taylor Pharmacy University Hospital Heidelberg Disclosure Relevant Financial Relationships
More informationAPPLICATION FOR SITE INSPECTION Eye Bank Association of America
APPLICATION FOR SITE INSPECTION Eye Bank Association of America Complete this application to begin the process for inspection and accreditation by the Eye Bank Association of America (EBAA). See the EBAA
More informationRegenerative Medicine and the Changing Regulatory Landscape
Regenerative Medicine and the Changing Regulatory Landscape May 3, 2018 Anne Marie Polak Leavitt Partners Gene Therapy CRISPR-Cas9 Inspired by genetic defense mechanisms found in bacteria Cas9 is an enzyme
More informationIn-State Licensee Newsletter January 2007
LOUISIANA BOARD OF WHOLESALE DRUG DISTRIBUTORS 12046 Justice Avenue, Suite C Baton Rouge, LA 70816 Phone: 225-295-8567 Fax: 225-295-8568 Website: www.lsbwdd.org email: lsbwdd@bellsouth.net In-State Licensee
More information6th Annual Somatic Cell Therapy Symposium Tissue & IND Products
6th Annual Somatic Cell Therapy Symposium Tissue & IND Products September 27, 2006 D. Michael Strong PhD, BCLD(ABB) Puget Sound Blood Center Northwest Tissue Center 10 Donor Centers Bellevue Central Seattle
More information8 th Regenerative Medicine and Stem Cells
8 th Regenerative Medicine and Stem Cells Theme: Light the Hope of Incurable Diseases March 19 21, 2 15 Busan, Republic of Korea Welcome Message Dear Friends and Colleagues, On behalf of the Organizing
More information